Administration of exogenous NaHS further enhanced tissue ERK1/2 activation in sepsis, whereby capsazepine treated, NaHS-injected septic mice revealed significantly reduced lung and liver phospho-ERK1/2 expressions (Fig. 9A). This evidence concerns the gene MAPK3 and Sepsis.